Streetbeat News

Products Services

MU

Micron Technology reported strong fiscal Q1 '25 earnings but issued weak Q2 '25 guidance, leading to a 16% share drop. Despite this, the company's HBM3E memory solutions are driving results, with significant DRAM revenue growth. The current valuation presents an attractive investment opportunity.

Portfolio Pulse from

December 19, 2024 | 3:30 pm

KROS

Levi & Korsinsky has initiated an investigation into Keros Therapeutics, Inc. (NASDAQ:KROS) for potential federal securities law violations. This follows Keros' announcement of halting certain treatment arms in a clinical trial due to safety concerns.

Portfolio Pulse from

December 19, 2024 | 3:30 pm

LLY

The U.S. FDA announced that the shortage of Eli Lilly's weight-loss drug has been resolved after a re-evaluation of the drug's supply.

Portfolio Pulse from

December 19, 2024 | 3:30 pm

SNN

Smith+Nephew has launched the CORIOGRAPH Pre-Op Planning and Modeling Services for Total Hip Arthroplasty, approved by the FDA. This service is part of the CORI Surgical System and offers personalized planning for surgeons using X-rays or CT scans.

Portfolio Pulse from

December 19, 2024 | 3:15 pm

SING

SinglePoint Inc., a renewable energy and sustainable lifestyle company, is exploring growth opportunities in air purification, electric vehicle charging, solar as a subscription service, and other sustainable solutions.

Portfolio Pulse from

December 19, 2024 | 3:15 pm

AYRWF

The US cannabis industry is expected to grow significantly due to increasing legalization and consumer demand. However, the sector remains volatile, especially among penny stocks, which require careful analysis and risk management.

Portfolio Pulse from

December 19, 2024 | 3:15 pm

DOW

Dow is partnering with Innventure's subsidiary, Refinity, to develop and commercialize waste-to-value technologies. This collaboration aims to convert mixed waste into valuable products, potentially enhancing Dow's sustainability initiatives.

Portfolio Pulse from

December 19, 2024 | 3:15 pm

SYTA

24/7 Market News has published an editorial about Siyata Mobile's upcoming press event on January 9, 2025, where the company will unveil a significant corporate milestone.

Portfolio Pulse from

December 19, 2024 | 3:15 pm

SRPT

Sarepta Therapeutics has completed enrollment for its phase III EMERGENE study, which evaluates an experimental gene therapy for an ultra-rare muscle disorder with no current treatment options beyond symptom management.

Portfolio Pulse from

December 19, 2024 | 3:00 pm

AFYA

Afya Limited has announced a share purchase agreement to acquire Faculdade Única de Contagem, expanding its presence in the medical education sector in Brazil.

Portfolio Pulse from

December 19, 2024 | 3:00 pm